PedAM
Pediatric Disease Annotations & Medicines
| Disease | hiv infections |
| Phenotype | C0001175|acquired immunodeficiency syndrome |
| Sentences | 5 |
| PubMedID- 25712776 | In 2012, about 1.6 million people worldwide died from acquired immunodeficiency syndrome due to hiv infection [1]. |
| PubMedID- 23029487 | hiv infection leads to the acquired immunodeficiency syndrome [3], opportunistic infections, and premature death. |
| PubMedID- 23028230 | The economic burden of human immunodeficiency virus (hiv) infection is well recognized globally.1–3 the hiv prevalence and incidence data presented in the last report by the united nations (unaids) and world health organization (who) show that 33.3 million people in the world were hiv-infected in 2009, with 2.5 million new cases.1 its management requires the use of health care services for treating hiv infection and symptoms associated with acquired immunodeficiency syndrome (aids) and with opportunistic infections, and involves indirect costs associated with morbidity and premature death of working-age patients. |
| PubMedID- 25120369 | Forty-five patients comprised the pharmacist intervention group and 45 the control group; all patients had hiv infection with or without acquired immunodeficiency syndrome. |
| PubMedID- 25747471 | Current understanding of the pathogenesis of invasive cryptococcal diseases is primarily based on clinical case series [5–11] and mouse experiments [12–17], which suggest that host conditions that impair cell-mediated immunity (cmi) (e.g., human immunodeficiency virus [hiv] infection with acquired immunodeficiency syndrome [aids], immunosuppressive therapy) play a critical role. |
Page: 1